Pharmather Holdings Financials
| PHRRF Stock | USD 0.16 0.01 5.88% |
With this module, you can analyze Pharmather financials for your investing period. You should be able to track the changes in Pharmather Holdings individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Pharmather |
The data published in Pharmather Holdings' official financial statements typically reflect Pharmather Holdings' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Pharmather Holdings' quantitative information. For example, before you start analyzing numbers published by Pharmather accountants, it's essential to understand Pharmather Holdings' liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Pharmather Holdings Stock Summary
Pharmather Holdings competes with Adial Pharmaceuticals, Transcode Therapeutics, Aditxt, Reviva Pharmaceuticals, and Avenue Therapeutics. PharmaTher Holdings Ltd., a clinical-stage psychedelics biotech company, focuses on the research, development, and commercialization of novel uses, formulations, and delivery methods of psychedelics to treat mental illness, neurological, and pain disorders. The company was incorporated in 2019 and is headquartered in Toronto, Canada. Pharmather Hldgs is traded on OTC Exchange in the United States.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| ISIN | CA71716H1082 |
| Business Address | 82 Richmond Street |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.pharmather.com |
| Phone | 888 846 3171 |
| Currency | USD - US Dollar |
Pharmather Holdings Key Financial Ratios
There are many critical financial ratios that Pharmather Holdings' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Pharmather Holdings reports annually and quarterly.| Return On Equity | -0.63 | |||
| Return On Asset | -0.25 | |||
| Beta | 2.98 |
Pharmather Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pharmather Holdings's current stock value. Our valuation model uses many indicators to compare Pharmather Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pharmather Holdings competition to find correlations between indicators driving Pharmather Holdings's intrinsic value. More Info.Pharmather Holdings is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pharmather Holdings' earnings, one of the primary drivers of an investment's value.Pharmather Holdings Systematic Risk
Pharmather Holdings' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Pharmather Holdings volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Pharmather Holdings correlated with the market. If Beta is less than 0 Pharmather Holdings generally moves in the opposite direction as compared to the market. If Pharmather Holdings Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Pharmather Holdings is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Pharmather Holdings is generally in the same direction as the market. If Beta > 1 Pharmather Holdings moves generally in the same direction as, but more than the movement of the benchmark.
Pharmather Holdings December 16, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Pharmather Holdings help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Pharmather Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Pharmather Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Pharmather OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Pharmather Holdings's daily price indicators and compare them against related drivers.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 48.53 | |||
| Value At Risk | (6.25) | |||
| Potential Upside | 11.76 |
Complementary Tools for Pharmather OTC Stock analysis
When running Pharmather Holdings' price analysis, check to measure Pharmather Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmather Holdings is operating at the current time. Most of Pharmather Holdings' value examination focuses on studying past and present price action to predict the probability of Pharmather Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmather Holdings' price. Additionally, you may evaluate how the addition of Pharmather Holdings to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Correlations Find global opportunities by holding instruments from different markets |